The global Epigenetics Drugs And Diagnostic Technologies Market size is expected to reach USD 22.05 billion by 2025, according to a new report by Grand View Research, Inc. It is projected to expand at a 19.7% CAGR during the forecast period. Rising incidence of cancer with epigenetic modification base is projected to drive the market growth.
Diagnostic firms are focused on developing new treatments such as antibodies specific for detection of epigenetic modifications and advanced kits for effective detection of biomarkers. It is likely to encourage pharmaceutical firms to partner for development of new advanced treatments which will further accelerate the market growth.
Presence of a large number of products under clinical trials and their projected commercialization is likely to boost the market. For instance, Eli Lilly’s Ramucirumab have been approved by the U.S. Food and Drug Administration (FDA) to be used in combination with Folfiri for the treatment of metastatic colorectal cancer.
Introduction of technologically advanced products in this space is mostly focused on detection of methylation markers associated with cancer development. For example, Epigenomics introduced Epi proLung BL Reflex Assay which helps in lung cancer diagnosis by determining methylation of SHOX2 biomarker gene.
Request a Sample Copy of the Global Microelectronic Medical Implants Market Research Report @ https://www.grandviewresearch.com/industry-analysis/epigenetics-drugs-and-diagnostic-technologies-market/request/rs1
Further key findings from the report suggest:
Have Any Query? Ask Our Experts@ https://www.grandviewresearch.com/inquiry/1495/ibb
Grand View Research has segmented the global epigenetics drugs and diagnostic technologies market on the basis of product, technology, type of therapy, application, and region:
Epigenetics Drugs and Diagnostic Technology Product Outlook (Revenue, USD Million, 2014 – 2025)
Epigenetics Drugs and Diagnostic Technology Outlook (Revenue, USD Million, 2014 – 2025)
Epigenetics Drugs and Diagnostic Technologies Type of Therapy Outlook (Revenue, USD Million, 2014 – 2025)
Epigenetics Drugs and Diagnostic Technologies Application Outlook (Revenue, USD Million, 2014 – 2025)
Epigenetics Drugs and Diagnostic Technologies Regional Outlook (Revenue, USD Million, 2014 – 2025)
Browse Related Category @
Contraceptive Drugs and Devices Market – https://www.grandviewresearch.com/industry-analysis/contraceptive-drugs-and-devices-industry
Antidiabetics Market – https://www.grandviewresearch.com/industry-analysis/antidiabetics-market
About Grand View Research
Grand View Research provides syndicated as well as customized research reports and consulting services on 46 industries across 25 major countries worldwide. This U.S.-based market research and consulting company is registered in California and headquartered in San Francisco. Comprising over 425 analysts and consultants, the company adds 1200+ market research reports to its extensive database each year. Supported by an interactive market intelligence platform, the team at Grand View Research guides Fortune 500 companies and prominent academic institutes in comprehending the global and regional business environment and carefully identifying future opportunities.
Media ContactCompany Name: Grand View Research, Inc.Contact Person: Sherry James, Corporate Sales Specialist – U.S.A.Email: Send EmailPhone: 1-415-349-0058, Toll Free: 1-888-202-9519Address:201, Spear Street, 1100 City: San FranciscoState: CaliforniaCountry: United StatesWebsite: www.grandviewresearch.com/industry-analysis/epigenetics-drugs-and-diagnostic-technologies-market